CS
Candriam SCA Portfolio holdings
AUM
$19.1B
1-Year Est. Return
27.91%
1 Year Est. Return
+27.91%
AUM
$17.3B
AUM Growth
+$1.38B
(+8.6%)
Holding
736
Top Buys
| 1 | +$108M | |
| 2 | +$55.5M | |
| 3 | +$45.5M | |
| 4 |
Boston Scientific
BSX
|
+$45.2M |
| 5 |
AbbVie
ABBV
|
+$32.4M |
Top Sells
| 1 | +$84.8M | |
| 2 | +$58.7M | |
| 3 | +$53.7M | |
| 4 |
Merck
MRK
|
+$39.1M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$38.2M |
Sector Composition
| 1 | Technology | 36.26% |
| 2 | Healthcare | 22.78% |
| 3 | Financials | 10.33% |
| 4 | Consumer Discretionary | 7.75% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CBRE Group
CBRE
$44.8B
| $22.5M | 0.13% |
160,654
-11,634
|
|
||
152
GE Aerospace
GE
$323B
| $22.4M | 0.13% |
87,069
-58,521
|
|
||
153
Twilio
TWLO
$19.3B
| $21.9M | 0.13% |
176,453
+1,881
|
|
||
154
MetLife
MET
$50.5B
| $21.8M | 0.13% |
270,687
-95,048
|
|
||
155
IBM
IBM
$288B
| $21.6M | 0.12% |
73,417
-44,012
|
|
||
156
Blackrock
BLK
$165B
| $21.6M | 0.12% |
20,567
+8,337
|
|
||
157
Quanta Services
PWR
$66.2B
| $21.3M | 0.12% |
56,358
+3,333
|
|
||
158
Carlisle Companies
CSL
$13.3B
| $21M | 0.12% |
56,311
-20,965
|
|
||
159
Intuit
INTU
$180B
| $20.6M | 0.12% |
26,183
+147
|
|
||
160
Agnico Eagle Mines
AEM
$80.3B
| $20.5M | 0.12% |
172,718
+152,762
|
|
||
161
Biogen
BIIB
$22.7B
| $20.5M | 0.12% |
163,315
-23,465
|
|
||
|
VRNA
162
DELISTED
Verona Pharma
VRNA
| $20.5M | 0.12% |
216,400
-81,355
|
|
||
163
Labcorp
LH
$20.4B
| $20.2M | 0.12% |
76,838
-262
|
|
||
164
Manulife Financial
MFC
$55.9B
| $20M | 0.12% |
626,180
+73,553
|
|
||
165
Crinetics Pharmaceuticals
CRNX
$4.06B
| $20M | 0.12% |
693,869
+204,958
|
|
||
166
Ventas
VTR
$35.3B
| $19.9M | 0.11% |
315,400
+271,734
|
|
||
167
CG Oncology
CGON
$2.96B
| $19.9M | 0.11% |
+763,580
|
|
||
168
Rhythm Pharmaceuticals
RYTM
$6.61B
| $19.7M | 0.11% |
312,452
+20,983
|
|
||
169
Texas Instruments
TXN
$146B
| $19.4M | 0.11% |
93,502
-94,157
|
|
||
170
IDEAYA Biosciences
IDYA
$2.61B
| $19.2M | 0.11% |
914,400
-23,777
|
|
||
171
Freeport-McMoran
FCX
$56.1B
| $19.2M | 0.11% |
442,965
+202,568
|
|
||
172
KLA
KLAC
$158B
| $19.1M | 0.11% |
21,376
-7,822
|
|
||
173
Ultragenyx Pharmaceutical
RARE
$2.98B
| $19.1M | 0.11% |
526,267
-201,750
|
|
||
174
Sherwin-Williams
SHW
$82.9B
| $19.1M | 0.11% |
55,695
-915
|
|
||
175
Citigroup
C
$180B
| $19.1M | 0.11% |
224,602
+5,827
|
|